Showing results (161-170 of 207) with videos related to

Sort By:
Pageof 21
Cancer Research|February 5, 2009
Human renal cancer cells express a novel membrane-bound interleukin-15 that induces, in response to the soluble interleukin-15 receptor alpha chain, epithelial-to-mesenchymal transitionKrystel Khawam, Julien Giron-Michel, Yanhong Gu, et al.
BMC Cancer|December 17, 2013
Expression of EPHRIN-A1, SCINDERIN and MHC class I molecules in head and neck cancers and relationship with the prognostic value of intratumoral CD8+ T cellsMeriem Hasmim, Cécile Badoual, Philippe Vielh, et al.
Oncotarget|February 25, 2016
The multifaceted role of autophagy in tumor evasion from immune surveillanceBassam Janji, Elodie Viry, Etienne Moussay, et al.
International Journal of Molecular Sciences|June 24, 2022
Genomic Analysis of Waterpipe Smoke-Induced Lung Tumor Autophagy and PlasticityRania Faouzi Zaarour, Mohak Sharda, Bilal Azakir, et al.
Seminars in Cancer Biology|November 29, 2023
Hypoxia as a potential inducer of immune tolerance, tumor plasticity and a driver of tumor mutational burden: Impact on cancer immunotherapyRaefa Abou Khouzam, Bassam Janji, Jerome Thiery, et al.
Cancer Gene Therapy|February 9, 2021
Nanomedicine-based cancer immunotherapy: recent trends and future perspectivesVinoth-Kumar Lakshmanan, Shlok Jindal, Gopinath Packirisamy, et al.
Cancer Immunology, Immunotherapy : CII|April 20, 2006
STEAP, a prostate tumor antigen, is a target of human CD8+ T cellsPedro M S Alves, Olivier Faure, Stéphanie Graff-Dubois, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 25, 2006
Identification of target actin content and polymerization status as a mechanism of tumor resistance after cytolytic T lymphocyte pressureSoraya Abouzahr, Georges Bismuth, Catherine Gaudin, et al.
Neoplasia (New York, N.Y.)|July 9, 2015
Human Renal Normal, Tumoral, and Cancer Stem Cells Express Membrane-Bound Interleukin-15 Isoforms Displaying Different FunctionsSandy Azzi, Cindy Gallerne, Cristina Romei, et al.
Frontiers in Oncology|March 27, 2023
State-of-the-art therapeutic strategies for targeting cancer stem cells in prostate cancerSaravanan Ramesh, Preethi Selvakumar, Mohamed Yazeer Ameer, et al.
Pageof 21